Clinical Research Directory
Browse clinical research sites, groups, and studies.
MDMA-Assisted Therapy for Mental Healthcare Providers
Sponsor: Rachel Yehuda
Summary
This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.
Official title: A Phase 1, Open-Label Study to Assess Psychological and Biological Effects of MDMA Assisted Therapy When Administered to Mental Health Providers in Training to be MDMA-Assisted Therapists
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-02-11
Completion Date
2029-12-21
Last Updated
2026-03-27
Healthy Volunteers
Yes
Conditions
Interventions
MDMA Hydrochloride
Initial dose of 120 mg MDMA HCl in a therapeutic setting, followed 1.5 to 2 hours later by a supplemental dose of 40 mg MDMA HCl. Supplemental doses may be withheld if tolerability issues emerge or it is declined by the participant.
Locations (1)
The Parsons Research Center for Psychedelic Healing
New York, New York, United States